ASTRIS: A multicenter, real world treatment study of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Cheema, P. K. [1 ]
Chen, Y-M. [2 ]
de Marinis, F. [3 ]
Freitas, H. C. [4 ]
Kim, S-W. [5 ]
Milner, A. [6 ]
Provencio, M. [7 ]
Rigas, J. [6 ]
Wu, Y-L. [8 ]
机构：
[1] Sunnybrook HSC, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[2] Natl Yang Ming Univ, Taipei, Taiwan
[3] Ist Europeo Milan, Div Thorac Oncol, Milan, Italy
[4] AC Camargo Canc Ctr, Sao Paulo, Brazil
[5] Asan Med Ctr, Seoul, South Korea
[6] AstraZeneca, Cambridge, England
[7] Hosp Clin Barcelona, Barcelona, Spain
[8] Guangdong Gen Hosp, Guangdon Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
141TiP
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC).
    De Marinis, Filippo
    Cho, Byoung Chul
    Kim, Dong-Wan
    Kim, Sang-We
    Hochmair, Maximilian J.
    Metro, Giulio
    Vansteenkiste, Johan F.
    Vicente, David
    Solomon, Benjamin J.
    Cheema, Parneet K.
    Freitas, Helano C.
    Provencio, Mariano
    Chen, Yuh-Min
    Wu, Yi-Long
    Milner, Alvin
    Rigas, James R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] ASTRIS China: A Real-world Study of Osimertinib in Patients with EGFR T790M Positive Non-small-cell Lung Cancer (NSCLC)
    Zhou, Q.
    Zhang, H. -L.
    Jiang, L. -Y.
    Shi, Y. -K.
    Chen, Y.
    Yu, J. -M.
    Zhou, C. -C.
    He, Y.
    Hu, Y. -P.
    Liang, Z. -A.
    Pan, Y. -Y.
    Zhuo, W. -L.
    Song, Y.
    Wu, G.
    Chen, G. -Y.
    Lu, Y.
    Zhang, C. -Y.
    Zhang, C. -Y.
    Zhang, Y. -P.
    Chen, Y.
    Lu, S.
    Wu, Y. -L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S429 - S430
  • [3] ASTRIS, a real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC): preliminary analysis of the Italian cohort
    Passaro, A.
    Metro, G.
    Tiseo, M.
    Migliorino, M. R.
    Santo, A.
    Sperandi, F.
    Maione, P.
    Puppo, G.
    Grossi, F.
    Parra, H. J. Soto
    Borra, G.
    Roca, E.
    Rocco, D.
    Stasi, I.
    Galetta, D.
    Carta, A. M.
    Milella, M.
    Fasola, G.
    Gebbia, V.
    Ferrari, S.
    De Marinis, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] ASTRIS global real world study of osimertinib in patients (pts) with EGFR T790M non-small cell lung cancer (NSCLC): Subpopulation analyses
    Provencio, M.
    Cheema, P. K.
    Vansteenkiste, J. F.
    Cho, B. C.
    Zhou, C.
    Yu, J.
    Martin, C.
    Park, K.
    He, Y.
    Hu, Y.
    Vicente, D.
    Miranda, M.
    Rigas, J.
    de Marinis, F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M-positive non-small cell lung cancer (NSCLC) European subset
    Tiseo, M.
    Santo, A.
    Hochmair, M. J.
    Geldart, T.
    Metro, G.
    Hanrahan, E.
    Lamberg, K.
    Moran, T.
    Nyhus, C.
    Paredes, A.
    Vansteenkiste, J. F.
    Vicente, D.
    Miranda, M.
    Rigas, J.
    de Marinis, F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] ASTRIS: A Real World Study of Osimertinib Treatment in Patients with EGFR T790M Positive Advanced NSCLC; Interim Analysis
    Kim, S.
    Cho, B. C.
    Kim, D.
    Park, K.
    Tiseo, M.
    Migliorino, M. R.
    Santo, A.
    Lee, J.
    Vicente, D.
    Paredes, A.
    O'Hanrahan, E.
    Freitas, H.
    Provencio, M.
    Chen, Y.
    Cheema, P.
    Milner, A.
    Rigas, J.
    Wu, Y.
    De Marinis, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2202 - S2202
  • [7] ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer
    de Marinis, Filippo
    Wu, Yi-Long
    de Castro Jr, Gilberto
    Chang, Gee-Chen
    Chen, Yuh-Min
    Cho, Byoung Chul
    Freitas, Helano C.
    Jiang, Liyan
    Kim, Sang-We
    Martin, Claudio
    Metro, Giulio
    Provencio, Mariano
    Vansteenkiste, Johan
    Vicente, David
    Zhou, Qing
    Miranda, Miguel F.
    Bakker, Nicolaas A.
    Rigas, James R.
    Cheema, Parneet K.
    FUTURE ONCOLOGY, 2019, 15 (26) : 3003 - 3014
  • [8] ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC
    Wu, Y.
    Cho, B. C.
    Zhou, Q.
    Chang, G.
    Jiang, L.
    Metro, G.
    Martin, C.
    De Castro, G.
    Vansteenkiste, J.
    Vicente, D.
    Milner, A.
    Rigas, J.
    Chen, Y.
    Provencio, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S358 - S359
  • [9] Real-World Study of Osimertinib in EGFR T790M-Mutated Non-Small Cell Lung Cancer (NSCLC): ASTRIS Canadian Cohort Analysis
    Cheema, P.
    Liu, G.
    Burkes, R.
    Owen, S.
    Yu, J.
    Hao, D.
    Rothenstein, J.
    Martel, S.
    Iqbal, M.
    Juergens, R.
    Lam, W.
    Laskin, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S803 - S803
  • [10] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Hirano, Toshiyuki
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
12345